Titre :
|
Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. (2000)
|
Auteurs :
|
W.S. CUTFIELD ;
K. ALBERTSSON-WIKLAND ;
H. BENNMARKER ;
P. CHATELAIN ;
D.A. PRICE ;
M.B. RANKE ;
P. WILTON ;
Pharmacla and Upjohn. Stockholm. SWE
|
Type de document :
|
Article
|
Dans :
|
Lancet (The) (vol. 355, n° 9204, 2000)
|
Pagination :
|
610-613
|
Langues:
|
Anglais
|
Mots-clés :
|
Diabète
;
Incidence
;
Hormone croissance
;
Thérapeutique
;
Thérapeutique médicamenteuse
;
Facteur risque
;
Enfant
;
Homme
;
Epidémiologie
;
Résultat
;
Glande endocrine [pathologie]
|
Résumé :
|
[BDSP. Notice produite par INIST ZR0x0xGJ. Diffusion soumise à autorisation]. Background Growth hormone (GH) contributes to insulin resistance, but whether children treated with GH are at increased risk of diabetes has not been established. We undertook a retrospective analysis of data from an international pharmacoepidemiological survey of children treated with GH to find out the incidence of impaired glucose tolerance and types 1 and 2 diabetes mellitus. Methods Reports to the survey of abnormal glucose metabolism were investigated and classified. The incidence and age-distribution of type 1 diabetes were compared with values from a model of reference data. The incidence of type 2 diabetes was compared with data from two reports of children not treated with GH. Findings 85 (0.36%) of 23 333 children were reported with abnormal glucose metabolism. After investigation, 43 had confirmed glucose disorders (11 with type 1 diabetes, 18 with type 2 diabetes, and 14 with impaired glucose tolerance). The incidence and age at diagnosis of type 1 diabetes in children treated with GH did not differ from expected values. The incidence of type 2 diabetes was 34.4 cases per 100 000 years of GH treatment which was six-fold higher than reported in children not treated with GH. Type 2 diabetes did not resolve after GH therapy was stopped. Interpretation GH treatment did not affect the incidence of type 1 diabetes mellitus in any age group. (...)
|